Efficacy and Safety of Mirabegron in Males with Overactive Bladder and Lower Urinary Tract Symptoms: Analysis from an Integrated Database
We conducted a combined analysis of 13 studies of mirabegron in males with overactive bladder with or without benign prostate enlargement. The analyzed patients included those taking mirabegron and mirabegron combined with other medications for lower urinary tract symptoms. Our results showed that mirabegron was safe and effective in reducing the symptoms of overactive bladder.
Authors
- Swapneel Anaokar
- Arianne Schild
- Farid Abdul Hadi
- Merete Kock Hansen
- Sender Herschorn (ORCID: https://orcid.org/0000-0001-8666-8236)
Institutions
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- Health Sciences Centre (CA)
- Astellas Pharma (China) (CN)
- Astellas Pharma (United Kingdom) (GB)
- Astellas Pharma (United States) (US)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1016/j.euros.2025.10.001
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00